317595-54-3

Usage

Uses

Used in Organic Synthesis:
N-Boc-1,2-Diaminocyclohexane is used as a building block for the synthesis of various compounds, including pharmaceuticals, agrochemicals, and materials, due to its versatile reactivity and the protective role of the Boc group in organic synthesis.
Used in Pharmaceutical Research:
In pharmaceutical research, N-Boc-1,2-Diaminocyclohexane is utilized as a chiral building block, contributing to the development of enantioselective reactions and the synthesis of biologically active molecules.
Used in Asymmetric Catalysis:
N-Boc-1,2-Diaminocyclohexane is employed as a chiral building block in asymmetric catalysis, facilitating the creation of enantiomerically pure compounds, which are crucial in the pharmaceutical industry for drug development.
Used in Metal-Catalyzed Reactions:
As a ligand in metal-catalyzed reactions, N-Boc-1,2-Diaminocyclohexane enhances the selectivity and efficiency of these reactions, making it a valuable tool in chemical research and development.

InChI:InChI=1/C11H22N2O2/c1-11(2,3)15-10(14)13-9-7-5-4-6-8(9)12/h8-9H,4-7,12H2,1-3H3,(H,13,14)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 694-83-7 rac-diaminocyclohexane 
• 1436-59-5 cis-cyclohexane-1,2-diamine 
• 21436-03-3 (S,S)-1,2-diaminocyclohexane 

Downstream Products

• 554-68-7 triethylamine hydrochloride 
• 1300730-77-1 ethyl 2-(4-(3-(2-(tert-butoxycarbonylamino)cyclohexyl)ureido)-2-chlorophenyl)acetate 
• 1443471-49-5 C₄₂H₄₆N₄O₄ 
• 1443471-48-4 C₃₃H₄₂N₂O₂ 
• 1443471-47-3 C₃₈H₅₀N₂O₄ 
• 1416225-78-9 C₂₀H₃₀N₂O₂ 
• 1416225-75-6 C₁₉H₂₈N₂O₂ 
• 1416225-74-5 C₁₈H₂₆N₂O₂ 

Relevant academic research and scientific papers

Characteristics of gelation by amides based on trans-1,2-diaminocyclohexane: The importance of different substituents

Six diamides were prepared from trans-(1R,2R)-1,2-diaminocyclohexane and the corresponding racemate and were subsequently used as gelators. Three chiral compounds and their racemates were prepared. One of the chiral compounds and its racemate contained tw

Design, synthesis and biological evaluation of novel estrogen-derived steroid metal complexes

A new series of estrogen-derived metal complexes were synthesized and characterized. The functionalized estrogen receptor ligands were prepared by a four-step synthetic strategy, and then three transition metal Pd, Ni, Zn were introduced readily to give t

Synthesis and antitubercular activity evaluation of novel unsymmetrical cyclohexane-1,2-diamine derivatives

A library of unsymmetrical cyclohexane-1,2-diamine derivatives were synthesized and evaluated for their activity against Mycobacterium tuberculosis H37Rv in vitro. Out of the 46 compounds synthesized, eight compounds (11h, 13a, 13e, 13f, 14a, 14c, 14d, an

Diamine derivatives

A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4??(1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

Cyclohexyl-triethylenetetraamine hexacetic acid

The present invention relates to new rigid chelating structures, to methods for preparing these materials, and to their use in preparing radiometal labeled immunoconjugates. These new chelates include cyclohexyl EDTA monohydride, the trans forms of cyclohexyl DTPA and TTHA, and derivatives of these cyclohexyl polyaminocarboxylate materials.

Cyclohexyl EDTA monoanhydride

The present invention relates to new rigid chelating structures, to methods for preparing these materials, and to their use in preparing radiometal labeled immunoconjugates. These new chelates include cyclohexyl EDTA monohydride, the transforms of cyclohexyl DTPA and TTHA and derivatives of these cyclohexyl polyaminocarboxylate materials.